Oweida, Ayman

Professeur, Faculté de médecine et des sciences de la santé
FMSS Dép. médecine nucléaire et radiobiologie

Coordonnées

Courriel


--

Diplômes

(2019) Post-doctorate (Postdoctoral Fellow). University of Colorado at Denver.

(2016) Doctorate (Experimental Medicine). McGill University.

(2006) Master's Thesis (Science - Masters). University of Western Ontario.

(2004) Diploma (Arts). University of Western Ontario.

(2004) Bachelor's (Medical Science). University of Western Ontario.

Expérience académique

(2019) Assistant Professor. Centre Hospitalier Univ. de Sherbrooke.

(2017-2019) Scientific Consultant - Imaging and Radiotherapy Core. University of Colorado at Denver.

(2017-2019) Senior Postdoctoral Fellow. University of Colorado at Denver.

(2017-2018) Immunology Consultant. ImmunoVaccine Inc.

(2016-2017) Postdoctoral Fellow. University of Colorado at Denver.

(2010-2011) Radiobiology Lab Manager. McGill University Health Centre.

Présentation

Sujets de recherche

Cancer Diagnosis and Detection, Head and Neck Cancer, Lung Cancer, Multiple Sclerosis, Radiotherapy.

Disciplines de recherche

Biology and Related Sciences, Oncology.

Mots-clés

Cellular Imaging, Head and Neck Cancer, Immunohistochemistry, Immunotherapy, Microscopy, Molecular Biology, MRI, Radiotherapy, Statistical Analysis, T cells.

Intérêts de recherche

Les travaux de Pr Oweida ont pour but d’améliorer la compréhension de l’effet des radiations sur le microenvironnement tumoral et de développer des stratégies afin de mitiger les effets négatifs des radiations sur la progression tumorale et l’apparition de métastases. Particulièrement, ses travaux portent sur l’étude des cancers de la tête et du cou par le biais de l’utilisation de techniques en biologie des radiations, biologie du cancer, immunologie et imagerie médicale. En parallèle à ses travaux sur la sur-expression de Tim-3 dans les cellules T comme mécanisme de résistance à la radiothérapie, et à l’utilisation de l’immunothérapie anti-PD-L1, Pr Oweida se concentre sur la caractérisation des mécanismes de radio-résistance et évasion immunitaire dans le cadre du cancer et à l’identification de biomarqueurs de résistance et de réponse aux traitements par radiations.

Centre de recherche

None

Langues parlées et écrites

Anglais, Français

Prix et distinctions

  • (2019) FRQS Postdoctoral Fellowship - Renewal. Fonds de recherche du Québec - Santé (FRQS). (Prize / Award).
  • (2019) FRQS Postdoctoral Fellowship (Ranked 1st/101 applications). Fonds de recherche du Québec - Santé (FRQS). (Prize / Award).
  • (2016) Distinct Fellow Recruitment Award. University of Colorado Denver. (Prize / Award).
  • (2014) Research and Travel Award. Ontario Institute for Cancer Research. (Prize / Award).
  • (2014) Travel Award. Canadian Statistical Sciences Institute. (Prize / Award).
  • (2014) Scholarship Ranked 1st of 484 in Province of Quebec. Fonds de recherche du Québec - Santé (FRQS). (Distinction).
  • (2014) Recognition of Research and Invitation to Travel to Present Findings. Canadian Cancer Society Research Institute. (Prize / Award).
  • (2013) CIHR Systems Biology Fellow. Canadian Institutes of Health Research. (Prize / Award).

Financement

Grant. (Awarded). Principal Investigator. Mechanisms of response and resistance to radio-immunotherapy in cancer. Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke Inc. (CRCHUS) (Sherbrooke, QC). Startup Fund. 180372 $ (2019-2022).

Grant. (Awarded). Principal Applicant. Identifier les Mechanismes de synergie entre la radiotherapie et I’ immunotherapie dans le cancer des voies aerodigestives superieures. Fonds de recherche du Québec - Santé (FRQS). Transfert de bourses postdoctorales en subventions de démarrage. 15000 $ (2019-2020).

Grant. (Awarded). Principal Investigator. Developing an imaging platform for identification of tumors that will respond to immunotherapy. Réseau de bio-imagerie du Québec. Projets pilotes. 13000 $ (2019-2020).

Grant. (Awarded). Principal Investigator. The role of tumor cell chemokines in regulating tumor immunogenicity. Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke Inc. (CRCHUS) (Sherbrooke, QC). Equipment Funding Program. 32700 $ (2019-2020).

Publications

Articles de revue

  • Hararah MK, Stokes WA, Oweida A, Patil T, Amini A, Goddard J, Bowles D, Karam SD. (2019). Epidemiology and Treatment Trends for Primary Tracheal Squamous Cell Carcinoma. The Laryngoscope, 130(2), 405-412. (Published).
  • Angela M Pierce, Davis A Witt, Andrew M Donson, Ahmed Gilani, Bridget Sanford, Martin Sill, Benjamin Van Court*, Ayman Oweida, Eric W Prince, Jenna Steiner, Etienne Danis, Kathleen Dorris, Todd Hankinson, Michael H Handler, Kenneth L Jones, Sana D Karam, Natalie J Serkova, Rajeev Vibhakar, Nicholas K Foreman, Andrea M Griesinger. (2019). Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma. Neuro-Oncology, 21(12), 1540-1551. (Accepted).
  • Bhatia S, Oweida A, Lennon S, Darragh L, Uyanga N, Bukkapatnam S, Millner D, Phan AV, Van Court B, Gill P, Raben D, Serkova NJ, Wang XJ, Jimeno A, Clambey ET, Pasquale EB, Karam SD. (2019). Inhibition of EphB4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers. Cancer Research, 79(10), 2722-2735. (Published).
  • Ayman Oweida Shilpa Bhatia Laurel Darragh Natalie Serkova Sana D Karam. (2019). Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment. Journal of Visual Experiments, 22, 146. (Published).
  • Laurel D Darragh Ayman J Oweida Sana D Karam. (2019). Overcoming resistance to combination radiation-immunotherapy: a focus on contributing pathways within the tumor microenvironment. Frontiers in Immunology, 9, 3154. (Published).
  • Lennon S, Oweida A, Millner D, Phan A, Bhatia S, Van Court B, Darragh L, Mueller A, Raben D, Torrecuadrada JM, Pitts T, Somerset H, Jordan K, Hansen K, Williams J, Messersmith W, Schulick R, Owens P, Goodman K, Karam SD. (2019). Pancreatic tumor microenvironment modulation by EphB4-ephrinB2 inhibition and radiation combination. Clinical Cancer Research, 25(11), 3352-3365. (Published).
  • Oweida A, Darragh L*, Phan A*, Binder D, Bhatia S, Mueller A*, Van Court B*, Millner D*, Raben D, Woessner R, Heasley L, Nemenoff R, Clambey E, Karam SD. (2019). STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer. Journal of the National Cancer Institute, 111(12), 36. (Published).
  • Karam SD, Reddy K, Blatchford PJ, Waxweiler T, DeLouize AM, Oweida A, Somerset H, Marshall C, Young C, Davies KD, Kane M, Tan AC, Wang XJ, Jimeno A, Aisner DL, Bowles DW, Raben D. (2018). Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer. Clinical Cancer Research, 24(20), 4949-4959. (Published).
  • Oweida A, Phan A*, Vancourt B*, Robin T, Pike L, Mohammad KH, Raben D, Haugen B, Pozdeyev N, Schweppe R, Karam SD. (2018). Hypofractionated radiotherapy is superior to conventional fractionation in an orthotopic model of anaplastic thyroid cancer. Thyroid, 28(6), 739-747. (Published).
  • Bhatia S, Sharma S, Bukkapatnam S, Oweida A, Lennon S, Phan AV, Milner D, Uyanga N, Jimeno A, Raben D, Somerset H, Heasley L, Karam SD. (2018). Inhibition of EphB4-ephrin-B2 signaling enhances response to Cetuximab-radiation therapy in head and neck cancers. Clinical Cancer Research, 24(18), 4539-4550. (Published).
  • Hararah MK, Stokes WA, Jones BL, Oweida A, Ding D, McDermott J, Goddard J, Karam SD. (2018). Nomogram for Preoperative Prediction of Nodal Extracapsular Extension or Positive Surgical Margins in Oropharyngeal Squamous Cell Carcinoma. Oral Oncology, 83, 73-80. (Published).
  • Oweida A, Hararah M, Phan A, Binder D, Bhatia S, Lennon S, Milner D, Bukkapatnam S, Van Court B, Uyanga N, Korpela S, Raben D, Tan AC, Heasley L, Clambey E, Nemenoff R, Karam SD. (2018). Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation and regulatory T-cell infiltration. Clinical Cancer Research, 24(21), 5368-5380. (Published).
  • Ayman Oweida Siham Sabri Areej Al-Rabea Mojgan Ebrahimi Russel Ruo Richard Fraser Jan Seuntjens Bassam Abdulkarim. (2018). Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer. Oncotarget, 9, 1630-1640. (Published).
  • Bhatia S, Griego AM, Lennon S, Oweida A, Sharma J, Rohmer C, Uyanga N, Bukkapatnam S, Vancourt B, Raben D, Young CD, Karam SD. (2018). Role of EphB3 receptor in mediating head and neck tumor growth, cell migration, and response to PI3K inhibitor. Molecular Cancer Therapeutics, 17(9), 2049-2059. (Published).
  • Azoulay M, Santos F, Shenouda G, Petrecca K, Oweida A, Guiot MC, Owen S, Panet-Raymond V, Souhami L, Abdulkarim BS. (2017). Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. Journal of Neuro-oncology, 132, 419-426. (Published).
  • Bhatia S, Hirsch K, Bukkapatnam S, Baig NA, Oweida A, Griego A, Calame D, Sharma J, Donson A, Foreman N, Albanese C, Venkataraman S, Vibhakar R, Karam SD. (2017). Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma. Cancer Cell International, 17, 41-50. (Published).
  • Ayman Oweida Shilpa Bhatia Kellen HIrsch Jaspreet Sharma Dylan Calame* Anastacia Griego Stephen Keysar Todd Pitts Gail Eckhardt Antonio Jimeno Gill Parkash Xiao-Jing Wang Joseph Califano Sana Karam. (2017). Ephrin-B2 Overexpression Predicts for Poor Prognosis andResponse to Therapy in Solid Tumors. Molecular Carcinogenesis, 56, 1189-1196. (Published).
  • Stokes WA, Binder DC, Jones BL, Oweida AJ, Liu AK, Rusthoven CG, Karam SD. (2017). Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy. Journal of Neuroimmunology, 313, 118. (Published).
  • Oweida A, Lennon S, Calame D, Korpela S, Bhatia S, Sharma J, Graham C, Binder D, Serkova N, Raben D, Heasley L, Clambey E, Nemenoff R, Karam SD. (2017). Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma. OncoImmunology, 6, e1356153. (Published).
  • Summer WA, Stokes WA, Oweida A, Berggren KL, McDermott JD, Raben D, Abbott D, Jones B, Gan G, Karam SD. (2017). Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy. Journal of Translational Medicine, 15, 168-177. (Published).
  • William A. Stokes, MD Bernard L. Jones, PhD Shilpa Bhatia, PhD Ayman Oweida, PhD Daniel W. Bowles, MD David Raben, MD Julie A. Goddard, MD Jessica D. McDermott, MD Sana D. Karam, MD PhD. (2016). A Comparison of Overall Survival for T4 Larynx Cancer between Surgical and Organ-Preservation Approaches, a National Cancer Data Base Analysis. Cancer, 123, 600-608. (Published).
  • Oweida A, Abdulkarim B. (2016). Ablative versus fractionated radiation therapy: a controversial role in cancer invasion and metastasis. Oncogene, 35(45), 5928. (Published).
  • Ayman Oweida, Zeinab Sharifi*, Hani Halabi, Yaoxian Xu, Siham Sabri, Bassam Abdulkarim. (2016). Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells. Cancer biology & therapy, 17(4), 390-399. (Published).
  • Shilpa Bhatia Kellen Hirsch Jaspreet Sharma Ayman Oweida Stephen Keysar Antonio Jimeno Xiao-Jing Wang Sana D Karam. (2016). Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas. Scientific Reports, 6, 38792. (Published).

Articles de conférence

  • Ayman J Oweida, Laurel Darragh*, Shilpa Bhatia, Benjamin Vancourt*, David Raben, Lynn Heasley, Raphael Nemenoff, Eric Clambey, Sana D Karam. (2019). Regulatory T cells mediate resistance to radiotherapy in head and neck squamous cell carcinoma. Journal of Clinical Oncology, (Published).
  • Oweida AJ, Phan A*, Vancourt B*, Robin T, Raben D, Haugen B, Pozdeyev N, Schweppe R, Karam SD. (2018). Radioresistant anaplastic thyroid cancers display a unique gene signature and respond to hypofractionated radiotherapy. AACR, (Published).
  • Oweida AJ, Hararah M*, Phan A*, Bhatia S, Lennon S*, Binder D, Raben D, Heasley L, Clambey E, Nemenoff R, Karam SD. (2018). Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation in anti-PD-L1 refractory head and neck cancer. AACR, (Published).
  • Oweida A, Calame D*, Lennon S*, Bhatia S, Sharma J, Caleb G, Raben D, Heasley L, Clambey E, Nemenoff E, Karam SD. (2017). Radiotherapy enhances T-cell infiltration and efficacy of PD-L1 blockade in murine orthotopic models of head and neck cancer. Journal of Clinical Oncology, 100-101. (Published).
  • Oweida A, Sharifi Z*, Ebrahimi M, Fraser R, Sabri S, Ruo R, Seuntjens J, Abdulkarim B. (2015). Differential Cellular and Molecular Response to Ablative Radiation in Non-Small Cell Lung Cancer Based on Molecular Subtype. Journal of Thoracic Oncology, S722. (Published).
  • Vasco Bravo-Filho*, Patrick T Logan, Sultan Aldrees, Natalia Vila, Ayman Oweida, Miguel N Burnier. (2015). Effects of ranibizumab and amfenac on the functional abilities of uveal melanoma cells. Investigative Ophthalmology & Visual Science, 5314. (Published).

Autres contributions

Cours enseignés

  • The Clonogenic Assay in Radiation Biology. (2015-06-17 à 2015-06-19). Niveau : Graduate.

Présentations

  • (2019). The role of regulatory T cells in the response to radiotherapy in cancer. Cancer Biology Seminar. Sherbrooke, Canada.
  • Sana Karam, Natalie Serkova. (2018). Animal Imaging Science Workshop - Nuts and Bolts. Department of Radiology. University of Colorado Denver - Anschutz medical campus. Aurora, United States.
  • None. (2018). Considerations in the adoption of immunotherapy for head and neck cancer patients. Department of Head and Neck Surgery Grand Rounds (Accredited CME Learning Session) at McGill University. Montreal, Canada.
  • None. (2018). Hypofractionated radiotherapy is superior to conventional radiotherapy in orthotopic mouse models of anaplastic thyroid cancer. Radiation Research Group. Aurora, United States.
  • None. (2018). Synergy of radiotherapy and immunotherapy in head and neck cancer. Cancer Research Seminars at McGill University. Montreal, Canada.
  • None. (2017). Mechanisms of synergy between immunotherapy and radiotherapy. Department of Nuclear Medicine and Radiobiology at Sherbrooke University. Sherbrooke, Canada.
  • None. (2017). Precision radiotherapy and image-guided tracking. Cancer Center Seminar. Aurora, United States.
  • None. (2017). Radiation-induced type I interferon signaling in lung cancer. Department of Radiation Oncology Monthly Seminar. Aurora, United States.
  • None. (2017). Transforming the immune landscape with radiation therapy in head and neck cancer. Lung and Head and Neck Cancer Program of the University of Colorado. Aurora, United States.
  • (2015). Mechanisms of Radioresistance in Orthotopic Animal Models of Non-Small Cell Lung Cancer. Radiation Oncology Rounds. Denver, United States.

Les informations disponibles dans la base de données Expertus sont tirées du CV commun canadien.